OncoImmunology Issues Research Articles in Vol. 12, No. 1
December 16, 2022
December 16, 2022
MILTON, England, Dec. 16 -- OncoImmunology, a peer-reviewed journal of tumor immunology, examining the natural or therapy-induced recognition of cancers and the interplay between oncogenesis, inflammation and immunosurveillance, published research articles on the following topics in its Vol. 12, No. 1 edition:
Original Research:
* ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-neg . . .
Original Research:
* ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-neg . . .